COVID-19 - Biopharma’s agility put at test

Scitaris, a leading biotech and pharma consultancy, is providing a perspective on the biological characteristics of the virus, including:

- implications on its transmission and potential ends to the pandemic

- focusing the race of the biopharma industry to finding a cure

- considerations for investors in the space